Senior insider sale
UNITED THERAPEUTICS CORP — senior position signals high conviction
$90.1K
187.00 shares
What this filing means
MESA NILDA plans to sell 187.00 shares of UNITED THERAPEUTICS CORP valued at approximately $90.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/9/2025ACC: 0001950047-25-010027
187.00
Shares to sell
$90.1K
Approx. market value
187.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock
Not Applicable
7/7/2023
187.00Total acquired187.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/7/2023 | Restricted Stock Not Applicable | 187.00 | — |
| Total | 187.00 | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
187.00
Market value
$90.1K
12/9/2025
Total
Units
187.00
Value
$90.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/9/2025 | 187.00 | $90.1K | NASDAQ | Planned |
| Total | 187.00 | $90.1K | ||